Carregant...
Bevacizumab inhibits proliferation of choroidal endothelial cells by regulation of the cell cycle
BACKGROUND: The purpose of this study was to evaluate cell cycle changes in choroidal endothelial cells treated with varying doses of bevacizumab in the presence of a range of concentrations of vascular endothelial growth factor (VEGF). Bevacizumab, a drug widely used in the treatment of neovascular...
Guardat en:
| Autors principals: | , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Dove Medical Press
2013
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3575188/ https://ncbi.nlm.nih.gov/pubmed/23430458 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OPTH.S41556 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|